Transcription of SIPA1 was high in lung cancer tumour and more advanced TNM stages of lung cancer, and the high level of SIPA1 correlated with the worst prognosis of lung cancer patients, which all indicate that SIPA1 can be used as a potential independent clinical biomarker to predict the prognosis and recurrence of lung cancer. The gene discussed is SIPA1; the disease is lung cancer.